Skip to content

AgomAb Therapeutics NV

AGMB· NasdaqCore metricsCIK 2020932

Biological products, except diagnostic substances175 peers

Last sale
Nov 12, 2026 · -9.38%
Market cap
$214.57M
34.17M shares
Filings
51
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
—
$214.57M
—
—
—
—
—

Price

$6.2857.13%$8.37since Feb 6, 2026
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of recordAs traded

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Common Shares Outstanding

34.17M shFY 2025
34.17M sh0FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-3134,167,168 shreported

Biological products, except diagnostic substances

AgomAb Therapeutics NV is the 88th largest of the 176 covered companies the SEC files under this code, by market cap. SIC 2836

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

AgomAb Therapeutics NV · CIK 2020932 · Engraved from SEC EDGAR